Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation (The ONE Study )
Clinical trial NCT02244801 · COMPLETED
Trial details
- NCT number
- NCT02244801
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2017-09-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.